logo-loader

Insight Widest with the analysis. We look at the companies others don’t, giving access to the opportunities others won’t.

bit bio hopes to scale gene engineering platform following rebrand

bit bio is hoping to build a scalable platform technology capable of producing any human cell type

Opinion We bridge the gap between knowledge and ignorance and give you the angle that hard facts alone won’t

Research Independent research from the expert Proactive analyst team

Revive Therapeutics - Revive Therapeutics: Analyst sees 'substantial upside potential' as key assets move towards clinic

Strategic Minerals

Revive Therapeutics: Analyst sees 'substantial upside potential' as key assets move...

Health

Revive Therapeutics:...

Revive Therapeutics (CSE:RVV, OTCQB:RVVTF) is a speciality life sciences company...

Health

Open Orphan: Focused on a...

Open Orphan (ORPH) is a specialist Contract Research Organisation (CRO) offering...

Health

Open Orphan: Scaling Up,...

Open Orphan PLC (LON:ORPH) is a specialist contract research organisation (CRO)...